XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,233,877 $ 2,115,869
Short-term investments 779,548 0
Accounts receivable 178,194 152,990
Inventory 198,997 186,212
Other current assets 140,331 149,028
Total current assets 2,530,947 2,604,099
Property and equipment, net 187,248 191,156
Intangible assets, net 13,328 14,239
Right of use assets 45,982 45,531
Other non-current assets 278,649 292,949
Total assets 3,056,154 3,147,974
Current liabilities:    
Accounts payable 54,007 76,741
Accrued expenses 293,908 271,697
Deferred revenue, current portion 89,244 89,244
Other current liabilities 17,803 15,051
Total current liabilities 454,962 452,733
Long-term debt 1,098,847 1,096,876
Lease liabilities, net of current portion 38,620 41,512
Deferred revenue, net of current portion 552,239 574,244
Contingent consideration 43,600 43,600
Other non-current liabilities 11,000 11,000
Total liabilities 2,199,268 2,219,965
Commitments and contingencies (Note 13)
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 3,333,333 shares authorized; none issued and outstanding 0 0
Common stock, $0.0001 par value, 198,000,000 shares authorized; 87,495,607 and 87,126,974 issued and outstanding at March 31, 2022, and December 31, 2021, respectively 9 9
Additional paid-in capital 4,168,956 4,134,768
Accumulated other comprehensive loss, net of tax (306) (20)
Accumulated deficit (3,311,773) (3,206,748)
Total stockholders’ equity 856,886 928,009
Total liabilities and stockholders’ equity $ 3,056,154 $ 3,147,974